Introduction
Lymph nodes (LNs) are organized anatomical structures distributed at strategic sites alongside the lymphatic vasculature that provide the hub of the acquired immune system. Their organization is supported by stromal cell populations, 1,2 allowing maximal interaction between antigen-loaded dendritic cells (DCs) migrating through the afferent lymphatic vasculature and recirculating lymphocytes entering through the blood vasculature. The combination of the markers CD31 (PECAM-1), Gp38/Podoplanin, CD35, and RANKL has allowed the identification of at least 5 stromal cell populations: blood endothelial cells (BECs; These populations are responsible for immune cell interaction and antigen presentation, ultimately providing the anatomical base for the organization of the acquired immune response. LN development begins during embryogenesis, following precise timing according to anatomical location: the mesenteric LNs develop first, followed by the others along the anterior-posterior axis. A key event is the recruitment and clustering of the hematopoietic lymphoid tissue inducer (LTi) cells expressing lymphotoxin a 1 b 2 . Engagement by LTi cells of the lymphotoxin b receptor (LTbR) on immature stromal cells will direct their maturation to lymphoid tissue organizer (LTo) cells that regulate further LTi cell clustering and development of the anlage. [5] [6] [7] The lymphatic vasculature is integral to LN structure; however, its importance in the development of the anlage remains unclear. Despite the development of the LN anlagen is synchronized with the formation of the lymph sacs, which characterize the beginning of the establishment of the lymphatic vasculature, 8, 9 LN formation is initiated normally in Prox-1
2/2
embryos which are devoid of lymph sacs and lymphatic vessels. 9 Due to the early lethality of Prox-1 2/2 embryos, the definitive outcome of the LN anlagen, which is disorganized in the absence of the lymphatic vasculature, remains unknown. In adult LNs, the lymphatic vasculature is embedded in the LN structure and interruption of the afferent lymphatic vessels has been shown to cause LN regression and loss of high endothelial venules (HEVs). 10 CLEC-2 (encoded by Clec1b), a C-type lectin-like receptor is an endogenous ligand for Gp38/Podoplanin expressed at high levels on megakaryocyte-derived platelets, inflammatory DCs, and possibly other hematopoietic cells. CLEC-2 contains a half immunoreceptor tyrosine-based activation motif (ITAM), also known as a hemITAM, and signals via the tyrosine kinase Syk, 11 mediating platelet activation and thrombus formation. [12] [13] [14] Deficiency in CLEC-2 or its ligand Gp38/Podoplanin results in systemic edema and abnormal lymphatic The online version of this article contains a data supplement.
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vasculature development characterized by blood-filled lymphatic vessels. [15] [16] [17] [18] [19] These defects are also seen in mice with deletions in genes encoding CLEC-2-signaling cascade proteins (Syk, SLP-76  and PLCg2   17 ), thus highlighting a role for CLEC-2 signaling in the development of the lymphatic vasculature. The molecular basis and anatomical location of the blood-lymphatic mixing has been proposed to occur at the level of the thoracic duct 20 and is no longer thought to be due to a defect in separation of the lymphatic endothelial cells from the cardinal vein. 21, 22 Additionally, studies using a soluble form of Podoplanin (Podoplanin-Fc) suggest that inhibition of Podoplanin function inhibits lymphangiogenesis. 23 Gp38/Podoplanin is expressed on different LN stromal cell populations in embryonic and adult life but the role of CLEC-2 in LN development and homeostasis has only recently been appreciated. Clec1b-deficient DCs have been shown to fail to access the Gp38 1 afferent lymphatics, reducing T-cell priming and antigen response in LNs, 24 while a role for CLEC-2 in HEV maintenance was reported during the revision of this manuscript. 25 In our study, we took advantage of the Clec1b PF4-Cre conditional mouse, in which Clec1b expression is selectively deleted on the megakaryocyte/platelet lineage, to dissect the role of CLEC-2 in the development of the LN anlage in the embryo and the maintenance of the LN structure and function in adult life.
Material and methods

Mice
Clec1b-deficient mice (Clec1b 2/2 and Clec1b fl/fl PF4-Cre) have been previously described. 16 Mice were bred and maintained in the Biomedical Service Unit at the University of Birmingham according to Home Office and local ethics committee regulations. Day of vaginal plug was designated as embryonic day 0 (E0). Bone marrow chimeras were generated after irradiation of C57BL/6 mice and reconstitution either with fetal liver isolated at E15.5 from Clec1b 2/2 or bone marrow from Clec1b fl/fl PF4-Cre. Six weeks after reconstitution, animals were sacrificed and LNs removed and analyzed.
Cell isolation
Embryonic, newborn, and adult LNs, mesenteries, intestine, and lungs were isolated and disaggregated to single-cell suspensions as previously described. 16 Cells were washed and resuspended in magnetic-activated cell sorting buffer for staining.
For analysis of draining and nondraining brachial LNs, individual LNs were teased apart using forceps, digested for 20 minutes at 37°C in RPMI with 0.3 mg/mL collagenase dispase and 100 mg/mL DNase I. Enzymatic digestion was stopped by addition of RPMI with 2.5 mM EDTA. Tissue suspensions were crushed through nylon mesh and a single-cell suspension collected. clone AFKJS-9 (eBioscience). CD31-FITCconjugated Ab was detected using rabbit anti-FITC (Sigma-Aldrich), then goat anti-rabbit IgG-FITC (Jackson ImmunoResearch Laboratories). Lyve-1 Ab was detected using goat anti-rabbit IgG-FITC (Jackson ImmunoResearch Laboratories). CXCL13 and CCL21 Ab were detected using donkey anti-goat FITC (Jackson ImmunoResearch Laboratories) then rabbit anti-FITC (SigmaAldrich), followed by goat anti-rabbit IgG-FITC (Jackson ImmunoResearch Laboratories). ER-TR7 was detected using donkey anti-rat FITC or Cy3 (Jackson ImmunoResearch Laboratories). Gp38/podoplanin was detected using goat anti-hamster biotin (Cambridge Bioscience). Biotinylated antibodies were detected using streptavidin-Alexa Fluor 555 or 488 (Molecular Probes). Sections were mounted using Vectashield mounting medium (Vector Laboratories).
LN immunization
Image acquisition and analysis of confocal images
Confocal images were acquired using a Zeiss LSM 510 laser-scanning confocal head with a Zeiss Axio Imager Z1 microscope. Digital images were recorded and stored as digital arrays of 2048 3 2048 pixels with 8-bit sensitivity; detectors were routinely set so that intensities in each channel spanned the 0 to 255 scale optimally.
Statistical analysis
Statistical significance was determined for all analysis in Figures 1 through 5 with a 2-tailed Student t test. In Figure 6 , statistical significance was determined by the 2-tailed Mann-Whitney test.
Results
Impaired LN development in Clec1b 2/2 embryos
To assess the effect of CLEC-2 loss on LN formation, we studied the formation of inguinal and mesenteric LNs in Figure 1B , third row). These results indicated that LN development is markedly impaired in Clec1b 2/2 mice ( Figure 1B ). Figure 1C and data not shown). This indicates that CLEC-2 is required for mesenteric LN development in late embryogenesis.
Lack of CLEC-2 expression in the megakaryocytes lineage does not affect LN development
To understand the lineage-specific requirements for CLEC-2 during LN development, we crossed mice carrying a conditional loxP-flanked allele of Clec1b (Clec1b fl/fl ) with a PF4-Cre transgenic mouse line to generate Clec1b fl/fl PF4-Cre mice that lack CLEC-2 expression in megakaryocytes and platelets. 16 These mice retain a phenotype characterized by red blood cells filling the lymphatic vessels but were viable. Macroscopic observation revealed that, in contrast to the Clec1b 2/2 mice, LNs were present in the
PF4-Cre mice (Figure 2A ), yet presenting a bloodied appearance.
14 Flow cytometric analysis showed normal recruitment of LTi cells and maturation of the stroma into LTo cells ( Figure 2B Figure 2C ). These differences suggest that, while CLEC-2 expression is necessary for LN embryological development, its source at this stage may derive from cells not belonging to the megakaryocyte lineage. We ruled out that the less severe phenotype observed in the Clec1b fl/fl PF4-Cre embryos was the consequence of a delay in the deletion of CLEC-2 on platelets due to the time needed for PF4 induction of the Cre enzyme in the embryo. Indeed, we showed that CLEC-2 is absent on platelets from E11.5 onwards in Clec1b We recently demonstrated that Clec1b 2/2 embryos have a defect in the number of LECs and a decrease in the LEC:BEC ratio in the intestine, mesenteries, and lungs, as well as blood-lymphatic mixing. 16 To better understand the function of CLEC-2 in endothelial cells, we analyzed the proliferation status of the LEC and BEC populations in Clec1b
and WT littermate embryos and newborns, focusing on the intestine, from which we could recover the higher number of LEC in embryonic life. The LEC compartment in the intestine is significantly reduced in E16.5 Clec1b PF4-Cre mouse strain were filled with red blood cells ( Figure 5A -B and data not shown) demonstrating that the absence of CLEC-2 expression by megakaryocytes/platelets is instrumental in maintaining vascular integrity in these structures. 16 Furthermore, this phenotype was associated with a significant defect in size and weight of mesenteric LNs ( Figure 5A ), whereas inguinal LNs showed a large degree of variability in these parameters ( Figure 5B ). Histological examination of the largest LNs in the Clec1b fl/fl PF4-Cre mice showed a generally preserved microscopic structure with normal B-/T-cell segregation and preserved marginal sinus ( Figure 5C ). In contrast, the smallest LNs (both mesenteric and inguinal) appeared fibrotic and showed a degree of histological disorganization and subversion of the follicular structure ( Figure 5D ).
In keeping with the results obtained in the embryos, stromal cell digestion and fluorescence-activated cell sorter analysis of Clec1b . These results suggest that, while the lack of CLEC-2 expression on megakaryocyte/platelets has a strong impact on the stability of the blood and lymphatic vascular bed and LN morphology, this is not reflected in a significant impairment of the lymphatic and stromal cell components.
Of interest, spleens isolated from Clec1b fl/fl PF4-Cre mice showed enlarged size as compared with the littermate controls (supplemental Figure 2A) . Nonetheless, histological examination of this tissue did not show major differences in spleen architecture and organization (supplemental Figure 2B) .
Loss of CLEC-2 expression in megakaryocytes/platelets does not compromise primary immune response
To investigate whether Clec1b For personal use only. on April 14, 2017 . by guest www.bloodjournal.org From LNs to support adaptive immune response, the endogenous PE-specific B-cell response was assessed after immunization in the paw pad with 10 mg of PE precipitated with alum ( Figure 6E 
CD38
2 PE-specific B cells ( Figure 6F ).
These PE-specific GCs also appeared comparable when assessed by immunofluorescence ( Figure 6G ). Combined, these data indicate that primary B-and T-cell responses in Clec1b fl/fl PF4-Cre LNs are normal.
Platelet CLEC-2 regulates LN function and stability in adult life
A recent study demonstrated that CLEC-2 expression on platelets is critical for the maintenance of the integrity of HEVs postimmune responses and its loss resulted in bleeding of peripheral LNs after immunization. 25 To test whether the loss of HEV integrity could affect the long-term B-and T-cell recirculation in the LN, we studied lymphocyte recruitment in Clec1b fl/fl PF4-Cre mice after several rounds of immunization. Mice were immunized in the front paw pad, with 10 mg of alum-precipitated NP-CGG on day 0, day 21, and day 42. Eight days after the last challenge, numbers of B and T cells were analyzed in the draining brachial LNs ( Figure 7A ). We demonstrated that repeated immunization gave rise to a reduced number of naive CD4 Figure 4A and data not shown). Accordingly, histological characterization of the LNs showed variable defects in LN architecture indicating the requirement of platelet/megakaryocyte-derived CLEC-2 for the maintenance of the LN structure (supplemental Figure 4B) . This defect was accompanied by a defect in recruitment of both CD4
1 and CD8 1 T cells in the LN postreconstitution with Clec1b fl/fl PF4-Cre bone marrow, suggesting that CLEC-2 was also important for the recovery of LN homeostasis after irradiation damage (supplemental Figure 4C) .
Discussion
In this study, by using both Clec1b 2/2 and Clec1b fl/fl PF4-Cre mouse models, in which Clec1b is either constitutively deleted on all cells or selectively on megakaryocytes and platelets, we demonstrated 2 distinct and nonredundant roles for CLEC-2 in lymphangiogenesis during embryogenesis and in LN homeostasis in adult life. We showed that constitutive lack of CLEC-2 expression determines defective lymphatic cell proliferation resulting in impaired development of the lymphatic vascular structures and involution of the LN anlagen in the embryo. In contrast, the deletion of CLEC-2 on the megakaryocyte/platelet lineage as in Clec1b fl/fl PF4-Cre mice allows formation of blood-filled LNs. We showed that absence of CLEC-2 on the megakaryocyte lineage in adult LN does not impair LN primary immune response, but determines long-term impairment in lymphocyte recruitment, ultimately indicating a role for CLEC-2 in the regulation of acquired immune response (see model, supplemental Figure 5 ).
Formation and maintenance of a functional lymphatic bed is critical for LN homeostasis in adult life. 28 However, due to the early lethality of knockout mice characterized by impaired formation of the lymphatic vessels, the requirement of the lymphatic vasculature for LN anlage development is still subject to debate. The 2 knockout mouse models used in this study showed different degrees of malformation in the lymphatic vasculature with a lymphatic phenotype characterized by a reduced number of LEC forming in the /Tie2Cre embryos, even though LTi cells were recruited into the LN anlagen, mature LTo cells fail to persist, suggesting that a normal lymphatic vasculature is critical for the stabilization and persistence of the LN anlage stroma.
In this study, we confirmed and extended previous findings demonstrating the nonredundant role of Clec1b in the regulation of LEC proliferation. 16 While our results suggest that this function is mediated in embryonic life by a cell type that does not belong to the megakaryocyte line (as Clec1b fl/fl PF4-Cre adult For personal use only. on April 14, 2017 . by guest www.bloodjournal.org From mice do not share this defect), we have not been able so far to detect expression of CLEC-2 on cells not belonging to the megakaryocyte/platelet or DC lineage (G.E.D. and K.L., manuscript in preparation).
Upon immunization, draining LNs undergo dramatic changes of the vascular and lymphatic beds 30 in which the axis Gp38/ Podoplanin/CLEC-2 might be involved at different levels. 31 Herzog et al demonstrated that platelets CLEC-2 is necessary to maintain HEV stability postlymphocyte migration. 25 In this manuscript, the author did not report on the impact of the loss of CLEC-2 on the immune response. Here we expand these observations and explore their functional relevance demonstrating that, while loss of CLEC-2 has no direct immunological consequences in the immune responses upon single immunization, LN status after chronic antigenic stimulation is largely impaired when CLEC-2 expression on platelets is missing. We showed that, in resting conditions, the size of LNs isolated from Clec1b fl/fl PF4-Cre mice are characterized by a high degree of variability. Nonetheless, no significant differences in lymphocyte composition and no defects in T-and B-cell immune responses upon primary immunization were observed in Clec1b Chronic antigenic stimulation is believed to represent a key event in the formation of ectopic lymphoid organs in autoimmune conditions. At these sites, HEVs have been described that are instrumental for naive and central memory cell recirculation. 32 Here, we propose that blockage of CLEC-2 activity in these conditions could represent a valid therapeutic approach, impairing lymphocyte migration and inducing ectopic lymphoid organ involution.
During the revision of this work, a manuscript describing CLEC-2 requirement to maintain lymphatic/blood system separation throughout life was published. 22 Here we expand this observation demonstrating that CLEC-2 expression is required for the maintenance of the immune response in adult life, as reconstitution of WT mice with Clec1b fl/fl PF4-Cre bone marrow but is associated with a significant decrease in T-cell number and disturbed histological appearance of the LNs. While further clarifications on the role of CLEC-2/Podoplanin interaction in chronic inflammation are needed, we are confident that this work establishes the functional role of CLEC-2 in LN development, maintenance, and physiological immune response.
